Malignancy Rate in Thyroid Nodules Classified as Bethesda Category III (AUS/FLUS)-Reference-Cited by-同舟云学术

Malignancy Rate in Thyroid Nodules Classified as Bethesda Category III (AUS/FLUS)

Published:2014-05 Issue:5 Volume:24 Page:832-839
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Ho Allen S.¹,Sarti Evan E.¹,Jain Kunal S.¹,Wang Hangjun²,Nixon Iain J.¹,Shaha Ashok R.¹,Shah Jatin P.¹,Kraus Dennis H.³,Ghossein Ronald²,Fish Stephanie A.⁴,Wong Richard J.¹,Lin Oscar²,Morris Luc G.T.¹

Affiliation:

1. Head and Neck Service, Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, New York.

2. Department of Pathology, Memorial Sloan–Kettering Cancer Center, New York, New York.

3. New York Head and Neck Institute, NorthShore-LIJ Health System, New York, New York.

4. Endocrinology Service, Department of Medicine, Memorial Sloan–Kettering Cancer Center, New York, New York.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2013.0317

Reference25 articles.

1. Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation

2. Perceptions of Diagnostic Terminology and Cytopathologic Reporting of Fine-Needle Aspiration Biopsies of Thyroid Nodules: A Survey of Clinicians and Pathologists

3. Thyroid Fine Needle Aspiration Cytology

4. The Bethesda System for Reporting Thyroid Cytopathology

Cited by 299 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Indeterminate Thyroid Nodules: A Model Comparing Surgery, Molecular Testing, and Observation;Otolaryngology–Head and Neck Surgery;2024-08-27

2. Automatic Classification of Nodules from 2D Ultrasound Images Using Deep Learning Networks;Journal of Imaging;2024-08-22

3. Evaluating the Diagnostic Role of ACR-TIRADS and Bethesda Classifications in Thyroid Nodules Highlighted by Cyto-Histopathological Studies;Experimental and Clinical Endocrinology & Diabetes;2024-08-05

4. METTL3-mediated m6A Modification of hsa_circ_0131922 Attenuates the Progression of Papillary Thyroid Cancer by Regulating the p53 Pathway;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-07-15

5. Improved Diagnostic Accuracy of Thyroid Fine-Needle Aspiration Cytology with Artificial Intelligence Technology;Thyroid®;2024-06-01